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It has recently been demonstrated that 2-aminoacetophenone (2-AA) is a chemical indicator in exhaled air/
breath of Pseudomonas aeruginosa infection associated with progressive life threatening decline of lung
function in cystic ﬁbrosis suﬀerers [Scott-Thomas et al., BMC Pulm. Med., 2010, 10, 56]. Currently the
detection of 2-AA involves laboratory based instrumentation such as mass spectrometry and a hand-
held point-of-care type breath device would be ideal in providing real-time results within seconds to
accelerate patient care decision-making processes. To this end, we demonstrate proof-of-concept that
the chemical marker 2-AA, indicative of Pseudomonas aeruginosa infection, can be measured using
electrochemical based sensing strategies. A range of commercially available electrode substrates are
explored demonstrating for the ﬁrst time that 2-AA is electrochemically active within aqueous based
solutions providing an (electro)analytical signal. Glassy carbon, boron-doped diamond and platinum
electrodes have been explored towards the electrochemical oxidation of 2-AA. Electrode fouling is
observed requiring pre-treatment in the form of mechanical polishing between voltammetric scans and
measurements. To alleviate this, screen-printed graphite electrodes are shown to be a more viable
option for implementation into breath sensing devices and overcome the fouling problem since due to
their low cost and disposable nature, a new electrode can be used for each measurement. The analytical
utility of the platinum, screen-printed and boron-doped diamond electrodes were found to correspond
to 6.85, 7.66 and 4.86 mM respectively. The challenges associated with the electrochemical sensing of
2-AA in breath that need to be overcome are discussed. This generic approach where electrochemical
based technology is used to provide measurements for chemical markers in exhaled air/breath for
medical diagnostics termed electrochemical breathprints (ec-breathprints), has the potential to be
developed into a hand-held point-of-care breath diagnostic tool for identifying Pseudomonas
aeruginosa infection in exhaled air/breath.Introduction
The analysis of exhaled air/breath is becoming widely accepted
as a non-invasive and rapid approach for clinical diagnostics in
the detection and diagnostics of diseases.1–9 So called Breath-
prints, where unique chemical signatures allow clinical diag-
nosis to be made, is gaining impetus building upon well-known
chemical markers, for example, such as nitric oxide in exhaled
breath of asthma suﬀerers,10,11 hydrogen and methane to assess
malabsorption of sugars in the small intestine, and the detec-
tion of Helicobacter pylori infection involving the ingestion of
isotopically-labelled compounds such as carbon-14 or non-Chemistry and the Environment, Division
nchester Metropolitan University, Chester
-mail: c.banks@mmu.ac.uk; Web: http://
612476831; Tel: +44 (0)1612471196
hemistry 2014radioactive carbon-13 with the detection of the isotope labelled
carbon dioxide.12 Current research is directed to nding new
chemical markers in breath/exhaled air that can provide clinical
diagnosis such as in the case of volatile organic compounds for
lung cancer,13,14 isoprene, acetone, trimethylamine, acetalde-
hyde, and pentane for non-alcoholic fatty liver disease in chil-
dren,15 isoprene for identifying end-stage renal disease,16
acetone for diabetes8 and nitric oxide for chronic obstructive
pulmonary disease17 to name just a few.
It is well established that hydrogen cyanide is a useful
biomarker,18–20 particularly for the indication of Pseudomonas
aeruginosa infection in cystic brosis (CF) patients.21 The char-
acteristics of CF are recurrent respiratory infections and chronic
inammation resulting in deterioration of lung function and
can eventually end in respiratory failure.21 Pseudomonas aeru-
ginosa is reported to be the most important respiratory infection
in CF and can result in a signicant increase in patientAnalyst, 2014, 139, 3999–4004 | 3999
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View Article Onlinemorbidity and mortality.22–24 If Pseudomonas aeruginosa infec-
tion can be diagnosed early and suitable antibiotic treatment is
undertaken, it can become eradicated before the infection
becomes chronic. The gold standard diagnosis is the culture of
expectorated sputum25 but it is reported, especially in young
children that patients are unable or unwilling to expectorate
sputum and the alternative of cough swabs are unreliable or
induced sputum samples which are time consuming, costly and
unpleasant.25 Consequently mouth and nose exhaled breath is
an appealing approach to overcome these clinical sampling
problems and provides a simple yet eﬀective non-invasive
approach for the identication of Pseudomonas aeruginosa
infection in cystic brosis patients.21
Recently pioneering work from Scott-Thomas and colleagues
reported that 2-aminoacetophenone (2-AA) is also a chemical
marker in exhaled air/breath for Pseudomonas aeruginosa
infection in CF suﬀerers.26 Follow-up work by Gilchrist et al.18
using SIFT-MS have independently conrmed that 2-AA can
indeed be a useful marker of pulmonary Pseudomonas aerugi-
nosa infection alongside hydrogen cyanide albeit that the
concentrations of 2-AA were observed to be lower than previ-
ously reported,26 though no reason was given.
In this work we demonstrate for the rst time that the
chemical marker for Pseudomonas aeruginosa infection,26 2-AA,
can be electroanalytically detected in aqueous based solutions
using electrochemical based technology and due to the elec-
trochemical mechanism, the use of disposable one-shot screen-
printed electrochemical sensors are favoured. Such electrodes
have the potential to be incorporated into a point-of-care breath
device providing useful clinical information of Pseudomonas
aeruginosa infection in CF patients.
Experimental
All chemicals were of the highest grade available and were used
as received (without further purication) from Sigma Aldrich
(UK). All solutions were prepared using deionised water of
resistivity no less than 18.2 MU cm and were vigorously
degassed prior to electrochemical measurements with high
purity, oxygen free nitrogen. For measurements involving
carbon dioxide and oxygen the solution was saturated (sepa-
rately) with the required gas via vigorously bubbling the solu-
tion for 20 minutes prior to electrochemical measurement. For
the introduction of 2-AA to solutions at xed concentrations an
Owlstone OCG-4 Gas Generator27 was utilised.
Voltammetric measurements were carried out using an m-
Autolab III (ECO-Chemie, The Netherlands) potentiostat. All
measurements were conducted using either: screen-printed
three electrode conguration (see below) with a geometric
working electrode area of 3 mm diameter, boron-doped
diamond (BDD), polycrystalline platinum or glassy carbon
(GC) electrode. The BDD and GC were mechanically polish-
ed/cleaned using a polishing pad and diamond sprays. The
platinum electrode was polished using alumina on a so
polishing pad.
Screen-printed carbon-based electrodes (denoted as SPEs)
were fabricated in-house with appropriate stencil designs using4000 | Analyst, 2014, 139, 3999–4004a microDEK 1760RS screen-printing machine (DEK, Weymouth,
UK). Note that this screen-printed electrode design has been
previously reported28–32 “as is” without electrode pre-treatment
or modication in various electroanalytical endeavours. For
fabrication of the SPEs, rst a carbon ink formulation (Product
Code: C2000802P2; Gwent Electronic Materials Ltd, UK) utilised
for the eﬃcient connection of all three electrodes and the
electrode material for both the working and counter electrodes
was screen-printed onto a polyester (Autostat, 250 micron
thickness) exible lm. The carbon ink layer was cured in a fan
oven at 60 degrees for 30 minutes. Next a silver/silver chloride
reference electrode was included by screen-printing Ag/AgCl
paste (Product Code: C2040308P2; Gwent Electronic Materials
Ltd, UK) onto the polyester substrates which was subsequently
cured once more in a fan oven at 60 degrees for 30 minutes.
Finally, a dielectric paste (Product Code: D2070423P5; Gwent
Electronic Materials Ltd, UK) was then printed onto the poly-
ester substrate to cover the connections and dene the active
electrode areas including that of the working electrode (3 mm
diameter). Aer curing at 60 degrees for 30minutes the SPEs are
ready to be used. These electrodes have been characterised
electrochemically in a prior paper and have heterogeneous rate
constants of 1.08  103 cm s1.33 The reproducibility and
repeatability of the fabricated batches of electrodes were
explored through comparison of cyclic voltammetric responses
using 1 mM hexaammine-ruthenium(III) chloride/0.1 M KCl.
Analysis of the voltammetric data revealed the % relative stan-
dard deviation to correspond to no greater than 0.82% (N ¼ 20)
and 0.76% (N ¼ 3) for the reproducibility and repeatability of
the fabricated SPEs for use in electroanalysis.
Results & discussion
We rst explore the validity of the electrochemical determina-
tion of 10 mM 2-AA using glassy carbon (GC) and boron-doped
diamond (BDD) electrodes in a pH 7 phosphate buﬀer solution.
The GC electrode was found to provide an electrochemical
signature with intriguing voltammetry noted. Oxidative vol-
tammetric peaks were observed at potentials of +0.07 V,
+0.26 V and +0.39 V (vs. Ag/AgCl) while a single reduction peak
was observed at 0.11 V (vs. Ag/AgCl). It was observed that
upon potential cycling each of the voltammetric peaks were
noted to grow. Since the peaks grow in magnitude rather than
reduce, such observations suggest that a conducting polymer is
being formed upon the electrode surface. To the best of our
knowledge there is only one electrochemical report on the
electrochemistry of 2-AA and related compounds which reports
that 2-AA can readily polymerise upon a GC electrode surface;34
such work veries our observations. In addition to GC being
explored as an electrode material, a BDD electrode was also
explored; such an electrode is routinely used in the eld of
electrochemistry since its robust surface has been reported to
exhibit less surface fouling compared to other carbon based
electrode substrates. The response of the BDD electrode
towards the electrochemical detection of 2-AA is shown in Fig. 1
which reveals that there are three oxidation peaks observed at
+0.17, +0.34 and +0.39 V (vs. Ag/AgCl) and a single reduction.This journal is © The Royal Society of Chemistry 2014
Fig. 1 Cyclic voltammetric measurements recorded in the absence (dotted line) and presence (solid line) of 60 mM 2-AA in a pH 7 phosphate
buﬀer solution using a boron-doped diamond electrode. Scan rate: 100 mV s1 (vs. Ag/AgCl). Inset: a typical calibration plot corresponding to
additions of 2-AA over the range of 10 to 60 mM using peak +0.34 V. Note that the electrode was polished between each measurement.
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View Article OnlineAgain, potential cycling revealed that the magnitude of each of
the described voltammetric peaks increased but the magnitude
of which was less than that observed at the GC electrode con-
rming less “fouling”, but the response is still far from ideal.
In order for the BDD electrode to be useful in electroanalysis,
mechanical polishing between voltammetric scans and addi-
tionally between measurements of 2-AA concentrations is
required. The electroanalytical response of the BDD was
explored with additions of 2-AA made into a pH 7 PBS using the
BDD electrode which was mechanically polished between each
addition and voltammetric measurement. Using the voltam-
metric peak observed at +0.34 V (vs. Ag/AgCl), analysis of the
voltammetric peak height (IP) as a function of concentration is
shown in the insert of Fig. 1 which reveals a linear range from 10
to 60 mM (IP (A) ¼ 1.69  108 (A mM1) + 5.33  108 (A); R2 ¼
0.98; N ¼ 6) beyond which the response is observed to plateau.
Since the voltammetric response at carbon electrodes appear
to involve the formation of a conducting polymer, the study was
expanded towards the potential utilisation of a noble metal
electrode substrate, namely polycrystalline platinum. As depic-
ted in Fig. 2 the successful electrochemical determination of 2-
AA is possible using the platinum electrode with the oxidation
potential noted to occur at +0.88 V (vs. Ag/AgCl). While only
one peak was initially observed, additional voltammetric peaks
appear in the anodic region upon potential cycling with a
reduction in the magnitude of the main peak; thus it is neces-
sary to mechanically polish the electrode between measure-
ments. The electroanalytical response at the platinum electrode
was explored with the voltammetric response monitored as aThis journal is © The Royal Society of Chemistry 2014function of 2-AA concentration additions into a pH 7 PBS where,
as shown in the insert of Fig. 2, a linear range of voltammetric
peak height against concentration is observed from 10 to 60
mM (IP (A) ¼ 1.35  106 (A mM1) + 2.46  105 (A); R2 ¼ 0.99;
N ¼ 6).
Next attention was turned to exploring the response of SPEs;
such electrodes can be used as one-shot electrochemical
sensors, that is, there is no need for electrochemical pre-treat-
ment in the form of mechanical polishing between measure-
ments greatly simplifying the analytical protocol.28–32
Additionally SPEs are more suited to point-of-care sensors than
other solid electrode substrates such as GC, BDD and platinum
due to the signicant cost benets of the SPEs. Fig. 3 displays
typical optical and SEM images of the SPEs used in this work
where a well-dened electrode surface is observed, consisting of
randomly orientated graphite particles bound together with an
inert polymeric binder which is free from cracks and holes. Note
the complete sensor depicted in Fig. 3 and utilised herein
comprises the dimensions of 4 cm  0.8 cm. Fig. 4 shows the
voltammetric response of 2-AA using a SPE. Inspection of Fig. 4
reveals that the electrochemical oxidation of 2-AA occurs using
the SPEs at a potential of +0.42 V (vs. Ag/AgCl) with the peak
for the reduction of the oxidised product occurring at a poten-
tial of 0.51 V (vs. Ag/AgCl). Additionally there is a small
oxidation wave at 0.26 V (vs. Ag/AgCl). Upon consecutive
potential cycling, using the same electrode, it was noted that
each of the voltammetric peaks increased in magnitude initially
before plateauing oﬀ aer 4 scans. However such fouling can
be avoided through the use of a new electrode for eachAnalyst, 2014, 139, 3999–4004 | 4001
Fig. 2 Cyclic voltammetric measurements recorded in 10 mM 2-AA in a pH 7 phosphate buﬀer solution using a polycrystalline platinum
electrode (solid line). Scan rate: 100 mV s1 (vs. Ag/AgCl). Inset: typical calibration plots corresponding to additions of 2-AA over the range of 10
to 60 mM using a polycrystalline platinum macroelectrode. Note that the electrode was polished between each measurement.
Fig. 3 An optical image (A) and SEM images at increasing magniﬁcations of a graphite screen-printed sensor (SPE).
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View Article Onlinemeasurement which is possible due to the low-cost nature of the
screen-printed electrodes. Next scan rate studies were per-
formed using the SPEs where analysis of the voltammetric peak
height was performed in terms of the peak current and peak
potential. A plot of peak current (IP) of the peak observed at
+0.42 V (vs. Ag/AgCl) against square root of the applied scan
rate was found to be linear over the range 5–200 mV s1
(IP (mA) ¼ 5.92  106 (A/(V s1)1/2)  6.5  106 (A); R2 ¼ 0.98;
N ¼ 7) suggesting a diﬀusional rather than a surface controlled
process, while the peak potential was found to shi to high
potentials with scan rate indicating an irreversible electro-
chemically process.
Having determined that the analyte, 2-AA, was electro-
chemically active at the SPEs, further information into the
electrochemical mechanism was sought. Cyclic voltammetric
measurements were conducted using the SPE sensor at a xed4002 | Analyst, 2014, 139, 3999–4004concentration of 2-AA using solutions of diﬀering pH's over the
range 2.3 to 10. A plot of pH versus voltammetric peak potential
(oxidation) yielded a line of best-t equation of EP (V) ¼ 0.028
(V per pH) + 0.60 (V); R2 ¼ 0.99. Note, based on this experi-
mentally deduced gradient of 28.2 mV per decade, such a value
is close to that expected for 1 proton and 2 electron process
(30 mV per pH unit at 25 C). While the exact mechanism is
unknown at this stage it likely involves the electrochemical
oxidation of the amino group which forms a polymer based on a
head-to-tail mechanism; such work has been reported before on
glassy carbon electrodes34 and also explains why polishing is
needed in-between voltammetric measurements; one-shot
economical SPEs alleviate this problem.
The electroanalytical response of the SPEs towards 2-AA was
last explored. Additions of 2-AA were made into a solution of pH
7.4 PBS where, as depicted in Fig. 4, (inset) linearity wasThis journal is © The Royal Society of Chemistry 2014
Fig. 4 Cyclic voltammetric measurements recorded in the absence (dotted line) and presence (solid line) of 10 mM 2-AA in a pH 7 phosphate
buﬀer solution using a graphite screen-printed electrode. Scan rate: 100 mV s1 (vs. Ag/AgCl). Inset: a typical calibration plot corresponding to
additions of 2-AA over the range of 10 to 40 mM. Note that each data point is a new sensor each time.
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View Article Onlineobserved (IP (A) ¼ 1.41  106 (A mM1) + 2.98  106 (A); R2 ¼
0.87; N ¼ 7) over a concentration range of 10 to 30 mM 2-AA
where upon further additions the response is seen to plateau,
likely due to saturation of the analyte upon the electrode surface
or arises from other factors; it is important to note that each
point on the insert of Fig. 4 is a new electrode and alleviates the
need for mechanical polishing between measurements as
observed for the other electrode substrates explored in this
study.
In comparison of the three materials explored the poly-
crystalline platinummacroelectrode oﬀered greatest sensitivity,
followed by the SPEs, while the BDD was noted to oﬀer vol-
tammetric peaks of diminished stature. Additionally the limits
of detection (3s) for the determination of 2-AA at the poly-
crystalline platinum macroelectrode, SPEs and BDD electrode
were calculated to be 6.85, 7.66 and 4.86 mM respectively. We
note however that for potential point-of-care measurements, the
SPEs are more ideally suited, especially given their low cost due
to scales of economy.
When considering the potential expansion of the electro-
chemical protocol towards the determination of 2-AA in breath
samples, exploration of the potential interferences, namely
carbon dioxide (CO2) and oxygen (O2) were conducted since they
are known to be electrochemically active. Separate electro-
chemical measurements (not shown) were carried using out an
SPE in a solution of pH 7.4 PBS containing 10 mM 2-AA with the
two gases being bubbled individually into the solutions (to
saturation) whereby it was noted that no change in the vol-
tammetric peak potential nor peak magnitude was noted. In
order to try and replicate breath samples, 2AA was explored as aThis journal is © The Royal Society of Chemistry 2014vapour. A 2-AA gas permeation tube27 was constructed with 2-AA
and used with a commercially available gas generator (see
Experimental) presented in the vapour phase into a 1 mL pH 7.4
PBS with bubbling undertaken for 20 seconds and 80 seconds.
The voltammetric signature was explored which was found to
approximately quadruple following the longer bubbling dura-
tion. It is noted that while a voltammetric response is possible
from gaseous 2-AA, extensive studies measuring 2-AA in real
breath will need to be undertaken and represents a signicant
challenge; see the Conclusions section for more details on
endeavor.Conclusions
In summary we have demonstrated that the chemical marker
indicative of Pseudomonas aeruginosa infection, 2-AA,26 can be
electrochemically detected at a range of electrode substrates
and can provide (electro)analytically useful measurements in
aqueous based solutions. Of particular note is that SPEs can be
used which alleviate the need for mechanical polishing between
measurements. For the application into a point-of-care device,
SPEs are ideally suited due to their relatively low cost and
disposable one-shot nature.
The challenges faced in translating an electrochemical
sensing approach to that of measuring markers in exhaled air/
breath are signicant. Firstly, more clinical trials on a large
population are clearly needed to conrm the exact levels or
expected distribution of 2-AA which are medically relevant due
to recent discrepancies between research groups;6,18 recent
results report that the quantity of 2-AA produced variesAnalyst, 2014, 139, 3999–4004 | 4003
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View Article Onlineaccording to the Pseudomonas aeruginosa genotype and the
interaction of genotype and phenotype.18 Secondly, since it is
known that bacteria produce a suit of relatively similar
compounds in complex mixtures,35 more extensive clinical trials
will reveal if there are other potential electrochemically active
interferents. Thirdly, the role of food sources, beverages,
cosmetics or medications which can give rise to false positive
have been explored but further extensive work is likely
required.36 Thirdly, can nasal breath also be used as is the case
for other well documented markers.37 However the main chal-
lenge faced to make this into a truly point-of-care breath device
involves developing breath sample collection and presentation
to the electrode surface/solution. In doing this, 2-AA in the
gaseous breath needs to be presented into an aqueous solution
for the electrochemical measurement to be conducted and this
will dilute the concentration of the marker (which will vary
depending on the chosen solution volume) and the choice of
solvent (aqueous or even non-aqueous) will determine the
solubility of 2-AA with a solvent that has a high solubility fav-
oured. At present the concentrations accessible using the elec-
trochemical approach are signicantly diﬀerent (higher) from
that reported for 2-AA in exhaled air/breath and in the head-
space of Pseudomonas aeruginosa cultures;18 in the latter an
average of 1.8 (range 0.1–13.8) ppbv has been reported. Conse-
quently a pre-concentration approach will be required with
multiple breath samples likely needed; as such this might be
unacceptable in a clinical diagnostic test; all such challenges
are currently being addressed.
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